Replies to post #188357 on Biotech Values

[mcbio]

I think you forgot to mention in your notes that ARQL will have a FOURTH molecule in the clinic before the end of 2015.

Was that the follow-on Akt inhibitor? I know they discussed how they were working on follow-on Akt inhibitors.